About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Bone Disease in Severely Burned Children | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 2/3NCT00591162

Bone Disease in Severely Burned Children

Bone metabolism is adversely affected by severe burns in children for a period of time.

Lead sponsor: The University of Texas Medical Branch, Galveston•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

The University of Texas Medical Branch, Galveston

More closely monitored biochemical and radiologic parameters of bone and mineral metabolism will increase the likelihood of earlier detection of abnormalities and possible therapeutic interventions.

Age

5 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Children age 5-18 years old with at least 40% or more of their body burned.

Exclusion Criteria

•Anyone with a burn covering less than 40% of the body or whose burn covers the front of both hipbones.
•Anyone younger than 5 years old, anyone with a history of cancer or other metabolic disease process, or anyone who is pregnant or has an allergy to Tetracycline will also be excluded.
•Anyone who has participated in an investigational drug trial within the past 60 days from date of admission will be excluded from this study.

Related studies

RECRUITINGPhase 2/3

Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients

NCT06807021 · Burn Scar, Burn Wound

RECRUITINGPhase 1/2

HUMSCs Combined With Col I to Third-Degree Burn Wound

NCT07530003 · Burn Wounds, Third-Degree Burn Wounds

The Effect of Hologram Application on Pain, Anxiety, and Fear Levels in Children During Burn Dressing

NCT06992895 · Burn Wounds, Burn

Blue Light for Donor Site Healing in Burn Patients

NCT07453927 · Donor Site Complication, Burn, and more

Building Community Resilience Program

NCT06771167 · Resilience, Psychological, Burnout, Psychological, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 6, 2014Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2/PHASE3

Enrollment254

Start dateOct 1992

Last updatedJun 6, 2014

Condition

Locations shown

U.T.M.B.

Galveston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 6, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions